ClinVar Miner

Submissions for variant NM_007294.4(BRCA1):c.3341AAG[1] (p.Glu1115del) (rs80358336)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 8
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) RCV000112075 SCV001161583 benign Breast-ovarian cancer, familial 1 2019-06-18 reviewed by expert panel curation IARC class based on posterior probability from multifactorial likelihood analysis, thresholds for class as per Plon et al. 2008 (PMID: 18951446). Class 1 based on posterior probability = 0.000998
Ambry Genetics RCV000129777 SCV000184586 uncertain significance Hereditary cancer-predisposing syndrome 2020-09-03 criteria provided, single submitter clinical testing The c.3344_3346delAAG variant (also known as p.E1115del) is located in coding exon 9 of the BRCA1 gene. This variant results from an in-frame AAG deletion at nucleotide positions 3344 to 3346. This results in the in-frame deletion of a glutamic acid at codon 1115. This variant has been reported in Italian and Turkish breast and/or ovarian cancer cohorts (Concolino P et al. Int J Mol Sci, 2019 Jul;20; Cecener G et al. Cancer Genet, 2020 Jan;240:23-32; Santonocito C et al. Cancers (Basel), 2020 May;12:). In addition, this alteration was classified as benign based on a multifactorial analysis model of variant classification (Parsons MT et al. Hum. Mutat. 2019 09;40:1557-1578). This amino acid position is poorly conserved in available vertebrate species. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
GeneDx RCV000513128 SCV000210039 uncertain significance not provided 2017-11-29 criteria provided, single submitter clinical testing This in-frame deletion of three nucleotides in BRCA1 is denoted c.3344_3346delAAG at the cDNA level and p.Glu1115del (E1115del) at the protein level. The normal sequence, with the bases that are deleted in brackets, is GAAG[delAAG]TAGT. This variant has not, to our knowledge, been published in the literature as pathogenic or benign. This variant was not observed at a significant allele frequency in large population cohorts (Lek 2016). This deletion of a single Glutamic Acid amino acid is not located in a known functional domain. In-silico analyses, including protein predictors and evolutionary conservation, support a deleterious effect. Since in-frame deletions may or may not inhibit proper protein functioning, the clinical significance of this finding remains unclear at this time and we consider BRCA1 Glu1115del to be a variant of uncertain significance.
CeGaT Praxis fuer Humangenetik Tuebingen RCV000513128 SCV000608816 uncertain significance not provided 2017-02-01 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000513128 SCV000699022 uncertain significance not provided 2017-02-16 criteria provided, single submitter clinical testing Variant summary: The c.3344_3346delAAG (p.Glu1115del) in BRCA1 gene leads to an in-frame deletion of Glu amino acid from a non-repeat region that is located outside of any known functional domain. The variant is present in the control population dataset of ExAC at frequency of 2.477e-05 (3/121130 chrs tested). The variant of interest has not, to our knowledge, been reported in affected individuals via publications, however UMD cites co-occurrence of the variant with a BRCA2 pathogenic mutation (c.5909C>A, p.Ser1970X). In addition, multiple reputable databases/clinical laboratories have classified the variant as VUS. Taking together, the variant was classified as VUS.
Invitae RCV000793753 SCV000933122 likely benign Hereditary breast and ovarian cancer syndrome 2020-08-07 criteria provided, single submitter clinical testing
Color Health, Inc RCV000129777 SCV001348544 uncertain significance Hereditary cancer-predisposing syndrome 2019-06-16 criteria provided, single submitter clinical testing
Breast Cancer Information Core (BIC) (BRCA1) RCV000112075 SCV000144731 uncertain significance Breast-ovarian cancer, familial 1 2004-11-25 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.